The extraordinary breakthrough in how ‘killer’ CD8 + T cells – the body’s ‘army of hitmen’ tasked with taking out new viruses – retain memories of virus strains they encounter was published in the prestigious Nature Communications journal this week (May 13).
University of Melbourne’s Associate Professor Katherine Kedzierska explained how the Australia-Sino collaboration began during the first outbreak of the avian-derived H7N9 virus in China in 2013.
That contagion saw 99% of people infected hospitalised, with a 30% mortality rate. Patient zero was an elderly man who caught the virus from a chicken his wife asked him to buy at the local live bird market.
“We’d never seen anything like H7N9,” Associate Professor Kedzierska said. “The virus was infecting more people rapidly and nobody had immunity. Thankfully, we did manage to contain the virus but we knew we had come face-to-face with a potential pandemic that could kill millions of people around the world if the virus became able to spread between humans,” she said.
“After collecting samples from infected patients we found that people who couldn’t make these T cell flu assassins were dying. These findings lead to the potential of moving from vaccines for specific influenza strains toward developing a protection, which is based on T-cells,” she said.
“From the 30% mortality rate in China we knew the clock was ticking on the situation. Had the contagion spread broken out globally, we’re talking about a history-altering event on the Spanish Flu scale. As it turns out, boosting the T cell adaptive memory capacity is our way in,” Associate Prof Kedzierska said.
“Our extraordinary breakthrough could lead to the development of a vaccine component that can protect against all new influenza viruses, with the potential for future development of a one-off universal flu vaccine shot,” she said. “This work will also help clinicians to make early predictions of how well a patient’s immune system will respond to viruses so they can manage early interventions such as artificial ventilation more effectively, particularly in cases where the patient is at risk of dying.”
The Latest on: Flu vaccine
via Google News
The Latest on: Flu vaccine
- A super-vaccine for the flu is being marketed to people 65 and older. Is it legit or a scam?on November 15, 2019 at 5:12 am
According to the Centers for Disease Control and Prevention, about 70%-80% of seasonal flu-related deaths occur in this age group. The regular flu vaccine just won't cut it, some doctors say. James ...
- Flu Jabs 2019: Know Where To Get Proper Flu Vaccineon November 15, 2019 at 3:50 am
The best recourse is to find out where to get the right vaccine. The National Health Service makes flu vaccine readily available for those who are considered at higher risk of contracting the illness.
- CDC: Getting Flu Shots Every Year Is The Best Way To Protect Yourself Against Influenzaon November 14, 2019 at 11:53 pm
Wondering why you should get vaccinated every year against the flu? Influenza is a potentially serious disease that can lead to hospitalizations and sometimes fatal outcomes. Every year during the flu ...
- Developing a Universal Flu Vaccineon November 14, 2019 at 12:04 pm
At the recent IDWeek meeting, a session on influenza vaccines examined how current vaccines are used and the future of influenza vaccines, including the development of broadly protective or what some ...
- Flu vaccine delay for schoolchildren across Scotlandon November 13, 2019 at 4:29 pm
"We are working with Public Health England, Health Protection Scotland, NHS boards and other relevant partners to ensure that all eligible children get their flu vaccine as soon as possible. "Those ...
- Pipetting-based immunoassay for point-of-care testing: Application for detection of the influenza A viruson November 13, 2019 at 2:53 am
This pipetting-based immunoassay was applied to detect the nucleoprotein (NP) of the influenza A virus. Using an HRP-conjugated monoclonal antibody as a probe, the assay allowed for specific and ...
- Child flu vaccine delay hits Highland primary schoolson November 13, 2019 at 2:13 am
NHS Highland has warned of delays affecting some child flu vaccinations in its area. A UK-wide delay in the delivery of the nasal spray Fluenz Tetra has meant the health board receiving fewer vaccines ...
- Influenza Vaccine Market Updates 2024 Key Players - GlaxoSmithKline, Merck, Pfizer, Novartis, Sinovac Biotechon November 13, 2019 at 1:47 am
Nov 13, 2019 (Profound via COMTEX) -- Get Sample Copy of this Report - https://www.novaoneadvisor.com/report/sample/998 TheGlobal Influenza Vaccine Marketis expected to grow steadily fromUSD3.13 ...
- Synergistic PA and HA mutations confer mouse adaptation of a contemporary A/H3N2 influenza viruson November 12, 2019 at 2:30 am
The mouse is the most widely used animal model for influenza virus research. However, the susceptibility of mice to seasonal influenza virus depends on the strain of mouse and on the strain of the ...
- Influenza Vaccine Market to Reach $6.20 Bn, Globally, by 2026 at 5.9% CAGR: Allied Market Researchon November 12, 2019 at 1:44 am
Influenza Vaccine Market to Reach $6.20 Bn, Globally, by 2026 at 5.9% CAGR: Allied Market Research PR Newswire PORTLAND, Oregon, Nov. 12, 2019 Surge in prevalence of influenza, technological ...
via Bing News